YuXXuJFSongM, et al.Associations of circulating microRNA-221 and 222 with the severity of coronary artery lesions in acute coronary syndrome patients. Angiology. 2021:33197211034286. DOI: 10.1177/00033197211034286. Epub ahead of print.
2.
FarooqVvan KlaverenDSteyerbergEW, et al.Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381:639-50.
3.
AkbogaMKCanpolatUYaylaC, et al.Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2016;67:89-95.
4.
AkbogaMKBalciKGMadenO, et al.Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark Med. 2016;10:375-83.
5.
AkbogaMKCanpolatUSahinarslanA, et al.Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis. 2015;240:110-4.
6.
YilmazSSenFAkbogaMK, et al.The relationship between resting heart rate and SYNTAX score in patients with stable coronary artery disease. Angiology. 2017;68:168-73.
7.
AkbogaMKYilmazSYalcinR. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation. Anatol J Cardiol. 2021. DOI: 10.5152/AnatolJCardiol.2021.03982. [Epub ahead of print].
8.
AkbogaMKYalcinRSahinarslanA, et al.Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease. Int J Cardiol. 2016;224:323-7.
